Clozapine Tablet
Product Images NDC 55154-3568

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Clozapine (NDC 55154-3568). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Bag Label (7c748f8a 73ce 4bd3 Aa30 9c66657f06ec 00)

Bag Label (7c748f8a 73ce 4bd3 Aa30 9c66657f06ec 00)
This text describes a medication called Clozapine in tablet form. The tablets each contain 100 mg of Clozapine USP. The usual adult dosage is provided in the product insert along with precautions and warnings. The medication should be stored at 20-25°C and dispensed in a tight container. The medication is distributed by Aurobindo Pharma USA, Inc and sold by Major Pharmaceuticals. The packaging is not child-resistant and is intended for institutional use only. The full product labeling should be consulted and dispensing should be contingent upon ANC results and should not exceed limits. The text provides the address for Aurobindo Pharma USA, Inc in East Windsor, NJ and for Major Pharmaceuticals in Livonia, MI, USA.*
FDA Label Image

Figure 1. Cumulative Probability Of A Significant Suicide Attempt Or Hospitalization To Prevent Suicide In Patients With Schizophrenia Or Schizoaffective Disorder At High Risk Of Suicidality (Clozapine Fig1)

Figure 1. Cumulative Probability Of A Significant Suicide Attempt Or Hospitalization To Prevent Suicide In Patients With Schizophrenia Or Schizoaffective Disorder At High Risk Of Suicidality (Clozapine Fig1)
The text describes a figure (Figure 1) that shows the cumulative probability of a significant suicide attempt or hospitalization to prevent suicide in patients with schizophrenia or schizoaffective disorder at high risk of suicidality. The figure includes data for treatments with Clozapine and Olanzapine over a period of time in months.*
FDA Label Image

Chemical Structure (Clozapine Str)

Chemical Structure (Clozapine Str)
This text indicates a chemical compound with the molecular formula CSHCIN and a molecular weight of 326.83.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.